08:00 , Nov 6, 2006 |  BC Week In Review  |  Company News

BioProgress, airPharma LLC, Zentiva N.V. deal

BPRG will acquire 10 marketed generic products for respiratory disease from airPharma for $4 million in upfront cash and $4 million in two tranches of stock payments, the latter being contingent on certain sales milestones....
08:00 , Nov 6, 2006 |  BioCentury  |  Finance

Ebb & Flow

When...
01:18 , Oct 31, 2006 |  BC Extra  |  Financial News

BioProgress raises L6.2M, acquires airPharma products

Drug delivery company BioProgress (LSE:BPRG; BPRG) raised L6.2 million ($11.7 million) in a private placement of 12.3 million shares at 50p, a 22% discount to Friday's close of 64.17p. BPRG said it will use the...
08:00 , Feb 6, 2006 |  BioCentury  |  Product Development

Emerging asthma treatments

Emerging asthma treatments...
08:00 , Mar 28, 2005 |  BC Week In Review  |  Company News

airPharma, Bespak plc deal

BPK will develop and manufacture an inhalation device for airPharma 's dry powder formulation of Zofac pumactant . airPharma plans to begin Phase II testing of the product in asthma this year. airPharma , Overland...
08:00 , Dec 6, 2004 |  BC Week In Review  |  Company News

airPharma management update

airPharma , Overland Park, Kan.   Business: Pulmonary   Hired: Peter Higuchi as VP of corporate development, formerly president and CEO of Cydex Inc.; and Ed Mitchell as VP of product development, formerly North American...
08:00 , Nov 15, 2004 |  BC Week In Review  |  Company News

airPharma, Britannia deal

airPharma received an exclusive global development and marketing license to AP0016 for all respiratory/pulmonary indications. The compound is a dry powder formulation of Britannia's protein-free synthetic surfactant Pumactant . airPharma will be responsible for all...
08:00 , Nov 9, 2004 |  BC Extra  |  Company News

airPharma, Britannia asthma deal

airPharma (Overland Park, Kan.) received a global development license to AP0016 , a dry powder formulation of Britannia's protein-free synthetic surfactant, Pumactant . airPharma will be responsible for all development and regulatory and marketing activities,...